Published in Heart on April 18, 2006
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail (2009) 2.51
The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes. Heart Fail Rev (2008) 0.99
An overview of glycemic control in the coronary care unit with recommendations for clinical management. J Diabetes Sci Technol (2009) 0.86
Cardiogenic diabetes. Heart Fail Rev (2014) 0.75
Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure. Cardiovasc Diabetol (2017) 0.75
A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol (1995) 9.27
Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J (2001) 5.77
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85
Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med (2001) 4.81
Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation (1997) 4.61
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol (1995) 4.50
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation (2003) 4.43
The epidemiology of heart failure. Eur Heart J (1997) 4.31
Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med (2004) 3.26
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation (1986) 2.69
Correlates of early hospital readmission or death in patients with congestive heart failure. Am J Cardiol (1997) 2.55
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol (2001) 2.45
Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol (2003) 2.10
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol (1997) 1.62
Anemia and its relationship to clinical outcome in heart failure. Circulation (2004) 1.61
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation (1991) 1.61
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol (1996) 1.55
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol (2002) 1.47
Predictors of prognosis in severe chronic heart failure. Am Heart J (1992) 1.46
Predicting mortality in patients with heart failure: a pragmatic approach. Heart (2003) 1.42
Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001. Heart (2003) 1.26
A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med (2004) 1.20
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J (2004) 1.13
Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J (2003) 1.10
Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur Heart J (2002) 1.05
Blood glucose: a strong risk factor for mortality in nondiabetic patients with cardiovascular disease. Am Heart J (2005) 0.93
Haemoglobin concentration and prognosis in new cases of heart failure. Lancet (2003) 0.84
Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Lond) (2000) 4.34
Anticardiolipin antibodies in an unselected stroke population. Lancet (1994) 3.66
Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J (2000) 1.95
C-reactive protein and outcome after ischemic stroke. Stroke (1999) 1.42
Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001. Heart (2003) 1.26
Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J (1999) 1.13
Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur J Heart Fail (2008) 1.11
Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart (2000) 1.07
The experiences of an acute stroke unit--implications for multicentre acute stroke trials. J Neurol Neurosurg Psychiatry (1993) 1.06
Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail (2001) 0.99
An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. Clin Sci (Lond) (1999) 0.93
Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction. Clin Sci (Lond) (1999) 0.90
Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning. Cardiovasc Res (2000) 0.86
Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study. Heart (2005) 0.85
An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure. Biochem Biophys Res Commun (1999) 0.83
Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose. Am Heart J (1993) 0.79
Combination therapy with tirofiban and enoxaparin in acute coronary syndromes. Int J Cardiol (1999) 0.78
The effect of valvular regurgitation on plasma Cardiotrophin-1 in patients with normal left ventricular systolic function. Eur J Heart Fail (2000) 0.78
Reduction in plasma concentrations of N terminal pro B type natriuretic peptide following percutaneous coronary intervention. Heart (2004) 0.77
T-ceIl recognition of discrete regions of the thrombolytic drug streptokinase. Clin Sci (Lond) (2000) 0.76
Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. Am J Cardiol (1993) 0.76
The Cardiac Insufficiency Bisoprolol Study II. Lancet (1999) 0.76
Anticardiolipin antibodies and cerebral infarction. J Neurol Neurosurg Psychiatry (1994) 0.75
Managing hypertension. BMJ (1992) 0.75
Towards a blood test for heart failure: the potential use of circulating natriuretic peptides. Br J Clin Pharmacol (2000) 0.75
Repeatability testing for transcranial Doppler sonography. Clin Sci (Lond) (1993) 0.75
Anticardiolipin antibodies (aCL) in patients following acute stroke. Acta Neurol Scand (1995) 0.75
Immunosuppressive treatment in stroke and renal failure. Ann Rheum Dis (1993) 0.75
Determinants of the blood pressure response to the first dose of ACE inhibitor in mild to moderate congestive heart failure. Br J Clin Pharmacol (1998) 0.75
Analysis of biogenic amines in plasma of hypertensive patients and a control group. Neurochem Res (1993) 0.75
Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat. Br J Anaesth (1983) 0.75
Actions of angiotensin II on cerebral blood flow autoregulation in health and disease. J Hypertens (1994) 0.75
Prolonged stability of endogenous cardiotrophin-1 in whole blood. Metabolism (2001) 0.75
Blood pressure and renin angiotensin system responses to initiation of treatment with captopril or losartan in heart failure. Br J Clin Pharmacol (1999) 0.75
The clinical pharmacology of ACE inhibitors: evidence for clinically relevant differences? Clin Exp Pharmacol Physiol Suppl (1992) 0.75